Home/SIWA Therapeutics/Lewis S. Gruber
LS

Lewis S. Gruber

CEO and Co-founder

SIWA Therapeutics

SIWA Therapeutics Pipeline

DrugIndicationPhase
SIWA318HPancreatic Ductal Adenocarcinoma (PDAC)Preclinical